Literature DB >> 14674858

Castration reduces the effect of serotonin-1A receptor stimulation on prepulse inhibition in rats.

Andrea Gogos1, Maarten van den Buuse.   

Abstract

This study examined the interaction between hormones and serotonin-1A (5-HT1A) receptor modulation of prepulse inhibition (PPI) of the acoustic startle response. Male and female rats were gonadectomized; some castrated rats received testosterone- or estrogen-filled implants. Rats were randomly injected with saline or 0.02 or 0.50 mg/kg 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a selective 5-HT1A receptor agonist. All rats showed a dose-dependent disruption of PPI in response to 8-OH-DPAT. In untreated castrated rats, this disruption was significantly reduced (33% compared with 78% in sham-operated rats). Testosterone treatment reversed this reduction, but estrogen was less effective. Ovariectomized and sham-operated rats showed similar PPI in response to 8-OH-DPAT. These data suggest that the effect of 8-OH-DPAT on PPI in male rats depends on circulating hormone levels, particularly testosterone. (c) 2003 APA

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14674858     DOI: 10.1037/0735-7044.117.6.1407

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  13 in total

1.  The importance of baseline in identifying 8-OH-DPAT-induced effects on prepulse inhibition in rats.

Authors:  A Gogos; M van den Buuse
Journal:  Br J Pharmacol       Date:  2007-02-05       Impact factor: 8.739

2.  Oestrogen modulation of the effect of 8-OH-DPAT on prepulse inhibition: effects of aromatase deficiency and castration in mice.

Authors:  Andrea Gogos; Sally Martin; Margaret E Jones; Maarten van den Buuse
Journal:  Psychopharmacology (Berl)       Date:  2006-08-01       Impact factor: 4.530

3.  The role of estrogen and testosterone in female rats in behavioral models of relevance to schizophrenia.

Authors:  Andrea Gogos; Perrin Kwek; Maarten van den Buuse
Journal:  Psychopharmacology (Berl)       Date:  2011-07-29       Impact factor: 4.530

4.  Male rats with the testicular feminization mutation of the androgen receptor display elevated anxiety-related behavior and corticosterone response to mild stress.

Authors:  Damian G Zuloaga; Jessica E Poort; Cynthia L Jordan; S Marc Breedlove
Journal:  Horm Behav       Date:  2011-07-23       Impact factor: 3.587

5.  Differential effects of estrogen and testosterone on auditory sensory gating in rats.

Authors:  Shane J Thwaites; Maarten van den Buuse; Andrea Gogos
Journal:  Psychopharmacology (Berl)       Date:  2013-08-09       Impact factor: 4.530

6.  Inhibition of 5α-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation.

Authors:  Paola Devoto; Roberto Frau; Valentina Bini; Giuliano Pillolla; Pierluigi Saba; Giovanna Flore; Marta Corona; Francesco Marrosu; Marco Bortolato
Journal:  Psychoneuroendocrinology       Date:  2011-10-24       Impact factor: 4.905

7.  The organizational role of testicular hormones and the androgen receptor in anxiety-related behaviors and sensorimotor gating in rats.

Authors:  Damian G Zuloaga; Cynthia L Jordan; S Marc Breedlove
Journal:  Endocrinology       Date:  2011-02-15       Impact factor: 4.736

8.  On again, off again effects of gonadectomy on the acoustic startle reflex in adult male rats.

Authors:  Jack C Turvin; William S Messer; Mary F Kritzer
Journal:  Physiol Behav       Date:  2006-12-12

9.  Selective enhancement of NMDA receptor-mediated locomotor hyperactivity by male sex hormones in mice.

Authors:  Maarten van den Buuse; Jac Kee Low; Perrin Kwek; Sally Martin; Andrea Gogos
Journal:  Psychopharmacology (Berl)       Date:  2017-07-03       Impact factor: 4.530

10.  Testosterone regulation of sex steroid-related mRNAs and dopamine-related mRNAs in adolescent male rat substantia nigra.

Authors:  Tertia D Purves-Tyson; David J Handelsman; Kay L Double; Samantha J Owens; Sonia Bustamante; Cynthia Shannon Weickert
Journal:  BMC Neurosci       Date:  2012-08-06       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.